134 related articles for article (PubMed ID: 21777959)
1. Comparison of rates and risk factors for development of osteoporosis and fractures after radical or partial nephrectomy.
Bagrodia A; Mehrazin R; Bazzi WM; Silberstein J; Malcolm JB; Stroup SP; Raheem O; Wake RW; Kane CJ; Patterson AL; Wan JY; Derweesh IH
Urology; 2011 Sep; 78(3):614-9. PubMed ID: 21777959
[TBL] [Abstract][Full Text] [Related]
2. Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy.
Malcolm JB; Bagrodia A; Derweesh IH; Mehrazin R; Diblasio CJ; Wake RW; Wan JY; Patterson AL
BJU Int; 2009 Aug; 104(4):476-81. PubMed ID: 19220252
[TBL] [Abstract][Full Text] [Related]
3. Comparison of rates and risk factors for development of anaemia and erythropoiesis-stimulating agent utilization after radical or partial nephrectomy.
Woldrich J; Mehrazin R; Bazzi WM; Bagrodia A; Kopp RP; Malcolm JB; Kane CJ; Patterson AL; Wan JY; Derweesh IH
BJU Int; 2012 Apr; 109(7):1019-25. PubMed ID: 21933323
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm.
Roos FC; Brenner W; Thomas C; Jäger W; Thüroff JW; Hampel C; Jones J
Urology; 2012 Mar; 79(3):607-13. PubMed ID: 22386408
[TBL] [Abstract][Full Text] [Related]
5. Does radical nephrectomy increase the risk of erectile dysfunction compared with partial nephrectomy? A cohort analysis.
Kopp RP; Dicks BM; Goldstein I; Mehrazin R; Silberstein JL; Colangelo CJ; Bagrodia A; Bazzi WM; Wake RW; Patterson AL; Kane CJ; Wan JY; Derweesh IH
BJU Int; 2013 Mar; 111(3 Pt B):E98-102. PubMed ID: 22757628
[TBL] [Abstract][Full Text] [Related]
6. [Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].
Boulière F; Crepel M; Bigot P; Pignot G; Bessede T; de la Taille A; Salomon L; Tostain J; Bellec L; Soulié M; Rischmann P; Bernhard JC; Ferrière JM; Pfister C; Albouy B; Colombel M; Zini L; Villers A; Rigaud J; Bouchot O; Patard JJ
Prog Urol; 2011 Nov; 21(12):842-50. PubMed ID: 22035910
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma.
Gratzke C; Seitz M; Bayrle F; Schlenker B; Bastian PJ; Haseke N; Bader M; Tilki D; Roosen A; Karl A; Reich O; Khoder WY; Wyler S; Stief CG; Staehler M; Bachmann A
BJU Int; 2009 Aug; 104(4):470-5. PubMed ID: 19239445
[TBL] [Abstract][Full Text] [Related]
8. Impact of renal surgery for cortical neoplasms on lipid metabolism.
Bagrodia A; Kopp RP; Mehrazin R; Lee HJ; Liss MA; Jabaji R; Kane CJ; Wake RW; Patterson AL; Wan JY; Derweesh IH
BJU Int; 2014 Dec; 114(6):837-43. PubMed ID: 24656182
[TBL] [Abstract][Full Text] [Related]
9. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
10. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
[TBL] [Abstract][Full Text] [Related]
11. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
[TBL] [Abstract][Full Text] [Related]
12. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
[TBL] [Abstract][Full Text] [Related]
13. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor.
Cost NG; Sawicz-Birkowska K; Kajbafzadeh AM; Tourchi A; Parigi GB; Guillén G; DeFoor WR; Apoznanski W
Urology; 2014 Jun; 83(6):1388-93. PubMed ID: 24768019
[TBL] [Abstract][Full Text] [Related]
14. Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis.
Barlow LJ; Korets R; Laudano M; Benson M; McKiernan J
BJU Int; 2010 Aug; 106(4):489-92. PubMed ID: 20039869
[TBL] [Abstract][Full Text] [Related]
15. Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy.
Takagi T; Kondo T; Iizuka J; Kobayashi H; Hashimoto Y; Nakazawa H; Ito F; Tanabe K
Int J Urol; 2011 Jun; 18(6):472-6. PubMed ID: 21481013
[TBL] [Abstract][Full Text] [Related]
16. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.
Scosyrev E; Messing EM; Sylvester R; Campbell S; Van Poppel H
Eur Urol; 2014 Feb; 65(2):372-7. PubMed ID: 23850254
[TBL] [Abstract][Full Text] [Related]
17. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Marechal JM; Klotz L; Skinner E; Keane T; Claessens I; Sylvester R; ; ; ;
Eur Urol; 2007 Jun; 51(6):1606-15. PubMed ID: 17140723
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors.
Jeon HG; Jeong IG; Lee JW; Lee SE; Lee E
Urology; 2009 Nov; 74(5):1064-8. PubMed ID: 19758688
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
Hutterer GC; Patard JJ; Colombel M; Belldegrun AS; Pfister C; Guille F; Artibani W; Montorsi F; Pantuck AJ; Karakiewicz PI
Cancer; 2007 Dec; 110(11):2428-33. PubMed ID: 17941033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
